A brief, intense workout may do more than boost fitness—it could help fight cancer. Researchers found that just 10 minutes of ...
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...
Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.
Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...
DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave. Researchers have now mapped this hidden architecture in unprecedented detail, showing ...
Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a ...
A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...
In a world where the immune system can be both hero and villain, three scientists have illuminated the path to taming its excesses. On October 6, 2025, ...
Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...
The Healthy @Reader's Digest on MSN

12 silent signs of skin cancer you’re probably ignoring

Dermatologists reveal the silent signs of skin cancer that are often overlooked, such as a pimple that doesn't go away. The ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...